This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pozzi C et al. (2004) Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 15: 157–163
Maes BD et al. (2004) Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study. Kidney Int 65: 1842–1849
Frisch G et al. (2005) Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial. Nephrol Dial Transplant 20: 2139–2145
Dal Canton A et al. (2005) One-year angiotensin-converting enzyme inhibition plus mycophenolate mofetil immunosuppression in the course of early IgA nephropathy: a multicenter, randomised, controlled study. J Nephrol 18: 136–140
D'Amico G (2004) Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 24: 179–196
Acknowledgements
The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Floege, J. Is mycophenolate mofetil an effective treatment for persistent proteinuria in patients with IgA nephropathy?. Nat Rev Nephrol 2, 16–17 (2006). https://doi.org/10.1038/ncpneph0067
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0067
This article is cited by
-
IgA-Nephropathie
Der Nephrologe (2011)
-
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
Kidney International (2010)
-
IgA-Nephropathie
Der Nephrologe (2008)